102.645 articles found

Sephin1 directly targets PHB2 to activate PINK1-PRKN-dependent mitophagy and alleviate α-synuclein neurotoxicity in Parkinson's disease models.

Ding XS, Wang B, Han Z, Cao J, Li YN, Feng CX, Wang YF, Guru JC, Wang XL, Yang Q, Qu Y, Gao L.

Biochem Pharmacol · 2026-09-25

DOI: 10.1016/j.bcp.2026.118498PMID: 42790826

microRNA-7-5p and α-Synuclein SAA Predict Parkinson's Disease Phenoconversion.

Zadegan S, Velammal P, Muthiah K, Jatty M, Adams C.

Ann Clin Transl Neurol · 2026-09-25

DOI: 10.1002/acn3.70539PMID: 42791197

Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson's disease.

Ganoza CA, Westenberger A, Paul JJ, Curado F, Somerville EN, Rennecke J, Bauer P, Beetz C.

NPJ Parkinsons Dis · 2026-09-25

DOI: 10.1038/s41531-026-01562-xPMID: 42791240

Reply to: Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson's disease.

Cogan G, Tesson C, Welment L, Clot F, LeGuern E, Lanore A, Dürr A, Cormier-Dequaire F, Debilly B, Planes M, Mangone G, Lesage S, Brice A.

NPJ Parkinsons Dis · 2026-09-25

DOI: 10.1038/s41531-026-01470-0PMID: 42791250

Editors' Note: The Muted Role of Vascular Risk Factors in Parkinson Disease and Associated Dementia.

Ganesh A, Galetta SL.

Neurology · 2026-09-25

DOI: 10.1212/wnl.0000000000218652PMID: 42789816

Reader Response: Midlife Vascular Risk Factors, Parkinson Disease, and Parkinson Disease-Dementia: The ARIC Study.

Adhya A, Tripathi M, Elavarasi A, Vetal D.

Neurology · 2026-09-25

DOI: 10.1212/wnl.0000000000214854PMID: 42789820

Author Response: Midlife Vascular Risk Factors, Parkinson Disease, and Parkinson Disease-Dementia: The ARIC Study.

Johri M, Gottesman RF.

Neurology · 2026-09-25

DOI: 10.1212/wnl.0000000000214893PMID: 42789821

Levodopa-induced dyskinesia provokes inflexible head-pelvis coordination during standing in Parkinson's disease.

Aderonmu JA, Dotov D, Curtze C.

Clin Biomech (Bristol) · 2026-09-25

DOI: 10.1016/j.clinbiomech.2026.106977PMID: 42801799

Increased risk of bipolar disorder following Parkinson's disease: A nationwide population-based cohort study.

Baik YJ, Hwang S, Kwon SW, Shin HJ, Kim S, Shin CH, Jin T, Yang D, Jung H, Bae Y.

J Psychiatr Res · 2026-09-25

DOI: 10.1016/j.jpsychires.2026.09.026PMID: 42815348

Lactoferrin-modified MSC-derived extracellular vesicles facilitate BBB penetration and enhance gastrodin-induced neuroprotection in Parkinson's disease: involvement of mitophagy.

Luo ZY, Han RJ, Guo TJ, Huang H, Su BH, Xu JL, Zhang W, Li JZ, Sang ZW, Mei ZT, Wang K, Zhang ZQ, An SJ, Chen HX.

Int J Pharm X · 2026-09-25

DOI: 10.1016/j.ijpx.2026.100674PMID: 42861415

Greater and Clinically Meaningful Improvement in Health-Related Quality of Life After Device-Aided Therapy in Younger Patients Earlier Within Advanced Parkinson’s Disease: Real-World Evidence from the DATs-PD GETM Spanish Registry

Santos García D, Solleiro Vidal Á, López Manzanares L, Martí Martínez S, González Ardura J, Gómez Esteban J, Delgado Ballestero T, González Ortega G, Cubo E, Solano B, Perona-Moratalla A, Escalante S, Monterde Ortega Á, Gil Martín M, López Blanco R, Borrué Fernández C, Martínez Torres I, García Ruíz P, Pareés Moreno I, Delgado Suárez C.

Medical sciences (Basel, Switzerland) · 2026-09-24

Greater and Clinically Meaningful Improvement in Health-Related Quality of Life After Device-Aided Therapy in Younger Patients Earlier Within Advanced Parkinson's Disease: Real-World Evidence from the DATs-PD GETM Spanish Registry.

Santos García D, Solleiro Vidal Á, López Manzanares L, Martí Martínez S, González Ardura J, Gómez Esteban JC, Delgado Ballestero T, González Ortega G, Cubo E, Solano B, Perona-Moratalla AB, Escalante S, Monterde Ortega Á, Gil Martín MP, López Blanco R, Borrué Fernández C, Martínez Torres I, García Ruíz P, Pareés Moreno I, Delgado Suárez C, DATs-Pd Getm Spanish Registry Group.

Medical sciences (Basel, Switzerland) · 2026-09-24

DOI: 10.3390/medsci14060602PMID: 42930521